| 产品描述: | ML-184 (CID2440433) is a selective GPR55 agonist with an EC50 of 250 nM and exhibits >100-fold selectivity for GPR55 over GPR35, CB1 and CB2. ML-184 induces phosphorylation of ERK1/2 and translocation of PKCβII to the plasma membrane by activating GPR55. ML-184(CID2440433) increases proliferation of neural stem cells and promotes neuronal differentiation in vitro |
| 靶点: |
GPR55 |
| 体内研究: |
ML-184 处理或与 Sitagliptin 联合处理均能改善高脂喂养 (HFF) 小鼠的糖耐量,增强胰岛素敏感性和胰岛素促泌反应。对胰岛 Ki-67 染色发现,ML-184可增加 HFF 小鼠的 β细胞增殖,并上调胰腺 GPR55、ERK1 和 ERK2 基因表达。 ML-184 能够增加高脂喂养 (HFF) 小鼠的 β 细胞面积和 β 细胞质量,减少 α 细胞面积和质量。ML-184 处理或与 Sitagliptin 联合处理,可显著增加循环 GIP 水平,减少小鼠的食物摄入量;增加空肠 GPR55 和 JNK1 基因表达水平。 |
| 参考文献: |
1. Kotsikorou E, et al. Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands. Biochemistry. 2011 Jun 28;50(25):5633-47. 2. Hill JD, et al. Activation of GPR55 increases neural stem cell proliferation and promotes early adult hippocampal neurogenesis. Br J Pharmacol. 2018 Aug;175(16):3407-3421. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.125 ml |
10.624 ml |
21.248 ml |
| 5 mM |
0.425 ml |
2.125 ml |
4.25 ml |
| 10 mM |
0.212 ml |
1.062 ml |
2.125 ml |
| 50 mM |
0.042 ml |
0.212 ml |
0.425 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |